Cargando…
Insights into auto-S-fatty acylation: targets, druggability, and inhibitors
Posttranslational S-fatty acylation (or S-palmitoylation) modulates protein localization and functions, and has been implicated in neurological, metabolic, and infectious diseases, and cancers. Auto-S-fatty acylation involves reactive cysteine residues in the proteins which directly react with fatty...
Autores principales: | Hu, Lu, Tao, Zhipeng, Wu, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637764/ https://www.ncbi.nlm.nih.gov/pubmed/34977571 http://dx.doi.org/10.1039/d1cb00115a |
Ejemplares similares
-
Druggable targets and therapeutic development for COVID-19
por: Duan, Xiaohua, et al.
Publicado: (2022) -
Non-antibiotic quorum sensing inhibitors acting against N-acyl homoserine lactone synthase as druggable target
por: Chang, Chien-Yi, et al.
Publicado: (2014) -
Monobodies as tool biologics for accelerating target validation and druggable site discovery
por: Akkapeddi, Padma, et al.
Publicado: (2021) -
Bioorthogonal pro-metabolites for profiling short chain fatty acylation
por: Sinclair, Wilson R., et al.
Publicado: (2017) -
In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
por: Michel, Maurice, et al.
Publicado: (2020)